These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 17062664)
41. Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells. Finkbeiner MR; Astanehe A; To K; Fotovati A; Davies AH; Zhao Y; Jiang H; Stratford AL; Shadeo A; Boccaccio C; Comoglio P; Mertens PR; Eirew P; Raouf A; Eaves CJ; Dunn SE Oncogene; 2009 Mar; 28(11):1421-31. PubMed ID: 19151767 [TBL] [Abstract][Full Text] [Related]
42. Mutation and expression analyses of the MET and CDKN2A genes in rhabdomyosarcoma with emphasis on MET overexpression. Chen Y; Takita J; Mizuguchi M; Tanaka K; Ida K; Koh K; Igarashi T; Hanada R; Tanaka Y; Park MJ; Hayashi Y Genes Chromosomes Cancer; 2007 Apr; 46(4):348-58. PubMed ID: 17243166 [TBL] [Abstract][Full Text] [Related]
43. Cigarette smoking induces overexpression of hepatocyte growth factor in type II pneumocytes and lung cancer cells. Chen JT; Lin TS; Chow KC; Huang HH; Chiou SH; Chiang SF; Chen HC; Chuang TL; Lin TY; Chen CY Am J Respir Cell Mol Biol; 2006 Mar; 34(3):264-73. PubMed ID: 16254251 [TBL] [Abstract][Full Text] [Related]
45. The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma. Herrera LJ; El-Hefnawy T; Queiroz de Oliveira PE; Raja S; Finkelstein S; Gooding W; Luketich JD; Godfrey TE; Hughes SJ Neoplasia; 2005 Jan; 7(1):75-84. PubMed ID: 15720819 [TBL] [Abstract][Full Text] [Related]
46. The function, proteolytic processing, and histopathology of Met in cancer. Hanna JA; Bordeaux J; Rimm DL; Agarwal S Adv Cancer Res; 2009; 103():1-23. PubMed ID: 19854350 [TBL] [Abstract][Full Text] [Related]
47. The role of Dickkopf-3 overexpression in esophageal adenocarcinoma. Wang Z; Lin L; Thomas DG; Nadal E; Chang AC; Beer DG; Lin J J Thorac Cardiovasc Surg; 2015 Aug; 150(2):377-385.e2. PubMed ID: 26093488 [TBL] [Abstract][Full Text] [Related]
48. Derivation and characterization of a Wilms' tumour cell line, WiT 49. Alami J; Williams BR; Yeger H Int J Cancer; 2003 Nov; 107(3):365-74. PubMed ID: 14506735 [TBL] [Abstract][Full Text] [Related]
49. Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions. Zeng G; Apte U; Micsenyi A; Bell A; Monga SP Exp Cell Res; 2006 Nov; 312(18):3620-30. PubMed ID: 16952352 [TBL] [Abstract][Full Text] [Related]
51. Met, the hepatocyte growth factor receptor, localizes to the nucleus in cells at low density. Pozner-Moulis S; Pappas DJ; Rimm DL Cancer Res; 2006 Aug; 66(16):7976-82. PubMed ID: 16912172 [TBL] [Abstract][Full Text] [Related]
52. Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line. Yi S; Tsao MS Neoplasia; 2000; 2(3):226-34. PubMed ID: 10935508 [TBL] [Abstract][Full Text] [Related]
53. Met proto-oncogene juxtamembrane rare variations in mouse and humans: differential effects of Arg and Cys alleles on mouse lung tumorigenesis. Zaffaroni D; Spinola M; Galvan A; Falvella FS; Pazzaglia S; Saran A; Mancuso MT; Galbiati F; Pignatiello C; Cabrera W; Ibanez O; Manenti G; Dragani TA Oncogene; 2005 Feb; 24(6):1084-90. PubMed ID: 15592501 [TBL] [Abstract][Full Text] [Related]
54. MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significance. Kanteti R; Yala S; Ferguson MK; Salgia R J Environ Pathol Toxicol Oncol; 2009; 28(2):89-98. PubMed ID: 19817696 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma. Watson GA; Zhang X; Stang MT; Levy RM; Queiroz de Oliveira PE; Gooding WE; Christensen JG; Hughes SJ Neoplasia; 2006 Nov; 8(11):949-55. PubMed ID: 17132227 [TBL] [Abstract][Full Text] [Related]
56. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Campbell DB; D'Oronzio R; Garbett K; Ebert PJ; Mirnics K; Levitt P; Persico AM Ann Neurol; 2007 Sep; 62(3):243-50. PubMed ID: 17696172 [TBL] [Abstract][Full Text] [Related]
57. Concurrent overexpression of Ets-1 and c-Met correlates with a phenotype of high cellular motility in human esophageal cancer. Saeki H; Oda S; Kawaguchi H; Ohno S; Kuwano H; Maehara Y; Sugimachi K Int J Cancer; 2002 Mar; 98(1):8-13. PubMed ID: 11857377 [TBL] [Abstract][Full Text] [Related]
58. Altered down regulation of the receptor tyrosine kinase met in pancreatic adenocarcinoma cells. Hill KS; Lorinczi M; Elferink LA J Exp Ther Oncol; 2010; 8(4):297-312. PubMed ID: 21222362 [TBL] [Abstract][Full Text] [Related]
59. Beta-catenin signaling involves HGF-enhanced HepG2 scattering through activating MMP-7 transcription. Pan FY; Zhang SZ; Xu N; Meng FL; Zhang HX; Xue B; Han X; Li CJ Histochem Cell Biol; 2010 Sep; 134(3):285-95. PubMed ID: 20677010 [TBL] [Abstract][Full Text] [Related]
60. C-met proto-oncogene expression in benign and malignant human renal tissues. Pisters LL; el-Naggar AK; Luo W; Malpica A; Lin SH J Urol; 1997 Sep; 158(3 Pt 1):724-8. PubMed ID: 9258068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]